StockData
Aethlon Medical Inc logo

Aethlon Medical Inc (AEMD) stock

AEMDNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$5.11+0.03 (+0.59%)

Close on Nov 18, 2026Market cap $3.63MP/E –Yield –

Aethlon Medical operating margin

Operating margin is operating income as a percentage of revenue.

Aethlon Medical's operating margin for the twelve months ending Mar 31, 2023 was -2072.0%. For fiscal 2023 it was -2072.0%, against -3542.5% the year before. The highest annual figure on record is -188.2% in fiscal 2014.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Mar 31, 2023-2072.0%+1470.5
FY2022Mar 31, 2022-3542.5%−2345.2
FY2021Mar 31, 2021-1197.3%−285.3
FY2020Mar 31, 2020-912.0%+1700.5
FY2019Mar 31, 2019-2612.5%+616.3
FY2018Mar 31, 2018-3228.8%−1673.4
FY2017Mar 31, 2017-1555.4%−1060.8
FY2016Mar 31, 2016-494.6%+29.1
FY2015Mar 31, 2015-523.7%−335.5
FY2014Mar 31, 2014-188.2%+102.5
FY2013Mar 31, 2013-290.7%−61.6
FY2012Mar 31, 2012-229.1%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2023CQ1 2023Mar 31, 2023-431.5%+1158.6
Q4 FY2022CQ1 2022Mar 31, 2022-28863.2%−22248.0
Q3 FY2022CQ4 2021Dec 31, 2021-14768.6%−14377.4
Q2 FY2022CQ3 2021Sep 30, 2021-1522.2%−658.7
Q1 FY2022CQ2 2021Jun 30, 2021-1590.1%−1378.2
Q4 FY2021CQ1 2021Mar 31, 2021-6615.2%−1394.6
Q3 FY2021CQ4 2020Dec 31, 2020-391.2%+1597.5
Q4 FY2020CQ1 2020Mar 31, 2020-863.5%−130.2
Q3 FY2020CQ4 2019Dec 31, 2019-212.0%+1487.0
Q1 FY2020CQ2 2019Jun 30, 2019-5220.6%−3665.2
Q4 FY2019CQ1 2019Mar 31, 2019-1988.6%−1413.9
Q1 FY2019CQ2 2018Jun 30, 2018-733.3%+23682.0
Q4 FY2018CQ1 2018Mar 31, 2018-1699.0%–
Q3 FY2018CQ4 2017Dec 31, 2017-1555.4%–
Q2 FY2017CQ3 2016Sep 30, 2016-574.7%–
Q1 FY2017CQ2 2016Jun 30, 2016-24415.4%–

More Aethlon Medical figures

See a number that looks wrong?